Artificial General Intelligence (AGI) could outperform human traders in crypto markets, impacting price movements and trading strategies.

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.